Inventor
RUDD MICHAEL T
US33 patents
⚠️ This page may combine multiple inventors who share the name “RUDD MICHAEL T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
17 patentsUS8377874B2Feb 19, 2013
HCV NS3 protease inhibitors
MERCK SHARP & DOHME9 citations84
US7879797B2Feb 1, 2011
HCV NS3 protease inhibitors
MERCK SHARP & DOHME15 citations84
US10512638B2Dec 24, 2019
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME8 citations82
US9278960B2Mar 8, 2016
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME4 citations82
US9328138B2May 3, 2016
HCV NS3 protease inhibitors
MERCK SHARP & DOHME8 citations80
US10933056B2Mar 2, 2021
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME2 citations71
US9663506B2May 30, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US9636337B2May 2, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US10239849B2Mar 26, 2019
Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME2 citations69
US10981902B2Apr 20, 2021
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME1 citations61
US11098029B2Aug 24, 2021
5-alkyl pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME1 citations60
US11655216B2May 23, 2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations49
US11339156B2May 24, 2022
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
MERCK SHARP & DOHME0 citations49
US10961215B2Mar 30, 2021
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations49
US10894775B2Jan 19, 2021
Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations48
US9738661B2Aug 22, 2017
HCV NS3 protease inhibitors
MERCK SHARP & DOHME0 citations41
US10752587B2Aug 25, 2020
Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use
MERCK SHARP & DOHME0 citations38
MERCK SHARP & DOHME LLC
6 patentsUS12331018B2Jun 17, 2025
Pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME LLC1 citations63
US12552767B2Feb 17, 2026
3-heteroaryl pyrrolidine and piperidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations51
US12497362B2Dec 16, 2025
Cyclopentapyrrole orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations51
US11826375B2Nov 28, 2023
Phosphinic amide prodrugs of tenofovir
MERCK SHARP & DOHME LLC0 citations50
US11680060B2Jun 20, 2023
Bicycloheptane pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations49
US12312332B2May 27, 2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations48